JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways
Cytoskeletal Signaling

Cytoskeletal Signaling

C9126 Darovasertib

Summary: A selective PKC inhibitor with preference for PKCα/θ, suitable for in vitro kinase and oncology research.
C9112 OSU-T315

Summary: An ILK inhibitor and signaling probe for in vitro AKT pathway research, for research use only.
C9105 NP-G2-044

Summary: A cytoskeleton-regulating compound targeting fascin, for in vitro migration and invasion studies.
C9068 ATN-161

Summary: A research-use pentapeptide targeting integrin α5β1, used for studies of cell adhesion and angiogenesis mechanisms.
C9065 Miransertib HCl

Summary: A selective allosteric pan-AKT inhibitor for research on the mechanisms of the PI3K/AKT pathway.
C9061 Cyclo(-RGDfK) TFA

Summary: A TFA salt of an RGD motif cyclic peptide that antagonizes αvβ3 integrin, for in vitro research experiments.
C5089 Linoleic Acid ethyl ester

Summary: An unsaturated fatty acid ester compound that can inhibit the Akt/GSK3β/β-catenin signaling pathway and NF-κB activation.

≥51.2 mg/mL
C4675 Acenocoumarol

Summary: A potent vitamin K epoxide reductase (VKOR) inhibitor and vitamin K antagonist.

≤0.2 mg/mL
C3844 Ingenol-3-angelate

Summary: A diterpene ester protein kinase C (PKC) modulator derived from Euphorbia peplus.

≤10 mg/mL
N2928 Dracohodin perochlorate

Summary: Dracohodin perochlorate is a synthetic small molecule investigated for modulation of cellular signaling pathways and utilized in mechanistic studies of inflammation and oncology biology.